394
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Effect of kefir and low-dose aspirin on arterial blood pressure measurements and renal apoptosis in unhypertensive rats with 4 weeks salt diet

, , , , &
Pages 1-8 | Received 01 Oct 2012, Accepted 20 Feb 2013, Published online: 30 Apr 2013

References

  • Kwok LO, Bernard MY, Cheung YBM, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 2007;49:69–75
  • Vasdev S, Gill V, Longerich L, et al. Salt-induced hypertension in WKY rats: prevention by α-lipoic acid supplementation. Mol Cell Biochem 2003;254:319–26
  • Haddy FJ. Role of dietary salt in hypertension. Life Sci 2006;79:1585–92
  • Pollard JM. Protecting your kidneys. Kidney Health Diabetes 2010;14:8
  • High blood pressure and kidney disease. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services; 2007
  • Plaut D, Mazzara A. Biomarkers of kidney failure: a brief review. J Contin Educ Topics Issues 2009
  • Darling IM, Morris ME. Evaluation of “true” creatinine clearance in rats reveals extensive renal secretion. Pharm Res 1991;8:1318--22
  • Cheng HF, Raymond CH. Cyclooxygenases, the kidney, and hypertension. Hypertension 2004;43:525–30
  • Peterson JG, Lauer MS. Using aspirin and ACE inhibitors in combination: why the hullabaloo? Cleve Clin J Med 2001;68:569--74
  • Roth GG, Calverley DC. Aspirin, platelets, and thrombosis: theory and practice. Blood 1994;83:885–98
  • Reusser M, McCarran D. Micronutrient effects on blood pressure regulation. Nutr Rev 1994;52:367–75
  • Aihara K, Kajimato O. Effect of powdered fermented milk with lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005;24:257–65
  • Florin M, Lo M, Liu KL, Sassard J. Salt sensitivity in genetically hypertensive rats of the Lyon strain. Kidney Int 2001;59:1865–72
  • Korhonen H. Milk-derived bioactive peptides: from science to applications. J Funct Foods 2009;1:177–87
  • Pihlanto A, Virtanen T, Korhonen H. Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. Int Dairy J 2010;20:3–10
  • Quiró SA, Hernández-Ledesma B, Ramos M, et al. Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. J Dairy Sci Am Dairy Sci Assoc 2005;88:3480–7
  • Matsuu M, Shichijo K, Okaichi K, et al. The protective effect of fermented milk kefir on radiation induced apoptosis in colonic cyrpt cells of rats. J Radiat Res (Tokyo) 2003;44:111–15
  • Tavernarakis N. Proteolytic pathways in necrotic cell death. BioTech Int 2006;16:1–4
  • Almeida PC, Oliveira V, Chagas JR, et al. Hydrolysis by cathepsin B of fluorescent peptides derived from human prorenin. Hypertension 2000;35:1278–83
  • Hsueh WA, Baxter JD. Human prorenin. Hypertension 1991;17:469–77
  • Neves FAR, Duncan KG, Baxter JD. Cathepsin B. Is a prorenin processing enzyme. Hypertension 1996;27:514–17
  • Brechler V, Chu WN, Baxter JD, et al. A protease processing site is essential for prorenin sorting to the regulated secretory pathway. J Biol Chem 1996;271:20636–40
  • Fukuda N, Satoh C, Hu WY, et al. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1999;19:1210–17
  • Liu JR, Wang SY, Chen MJ, et al. The anti-allergenic properties of milk kefir and soymilk kefir and their beneficial effects on the intestinal microflora. J Sci Food Agric 2006;86:2527–33
  • Escribano M, Molero L, López-Farré A, et al. Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development. Clin Sci 2004;106:83–91
  • Ichihara K, Haneda T, Onodera S, Abiko Y. Inhibition of ischemia-induced subcellular redistribution of lysosomal enzymes in the perfused rat heart by the calcium entry blocker, diltiazem. J Pharmacol Exp Ther 1987;242:1109–13
  • Kirschke H, Wood L, Reisen F. Activity of lysosomal cysteine proteinase during differentiation of rat skeletal muscle. Biochem J 1983;214:871–7
  • Zovein A, Flowers-Ziegler J, Thamotharan S, et al. Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol 2004;286:273–82
  • Atroshi F, Rizzo A, Biese L, et al. Fumonisin B1-induced DNA damage in rat liver and spleen: effect of pretreatment with coenzyme Q10, L-carnitine, α-tocopherol and selenium. Pharmacol Res 1999;40:459--67
  • Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol 1957;10:447–55
  • Nishiitsutsuji-Uwo JM, Ross BD, Krebs HA. Metabolic activities of the isolated perfused rat kidney. Biochem J 1967;103:852–62
  • Kokko and Tannen, Fluids and Electrolytes, 1986
  • Rout SK, Dutta S, Sengupta M, et al. Anti hypertensive therapy: the concepts of management with herbal and synthetic agents for pulmonary hypertension. Int J Pharm Sci Rev Res 2010;3:72--9
  • Derkx FHM, Tan-Tjiong L, Veld AJM, et al. Activation of inactive plasma renin by tissue kallikreins. J Clin Endocrinol Metab 1979;49:765–9
  • Wang PH, Do YS, Macaulay L, et al. Identification of renal cathepsin B as a human prorenin-processing enzyme. J Biol Chem 1991;266:12633–8
  • Hamet P, Richard L, Dam TV, et al. Apoptosis in target organs of hypertension. Hypertension 1995;26:642–8
  • Kuwabara Y, Nagai S, Yoshimitsu N, et al. Antihypertensive effect of the milk fermented by culturing with various lactic acid bacteria and a yeast. J Ferment Bioeng 1995;80:294–5
  • Dubey K, Balani DK, Pillai KK. Potential adverse interaction between aspirin and lisinopril in hypertensive rats. Hum Exp Toxicol 2003;22:143–7
  • Savenkov MP, Ivanov SN, Brodskaia SA. Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents. Ter arkh 2001;73:27–31
  • Przewłocka-Kosmala M. The effect of acetylsalicylic acid on hypotensive action of enalapril in hypertensive patients. Przegl Lek 2002;59:76–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.